Patent No. EP2906536 (titled "An Improved Process For Preparation Of Perindopril Intermediate") was filed by Piramal Enterprises on Oct 4, 2013. The application was issued on Mar 14, 2018.
A process for preparing the key intermediate (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid benzyl ester (Perindopril benzyl ester) used in the synthesis of the ACE inhibitor Perindopril. The process involves reacting the compound of formula III with the compound of formula IV in the presence of 1-hydroxybenzotriazole (HOBT), dicyclohexylcarbodiimide (DCC), and triethylamine in toluene at 5-40°C. The reaction avoids the formation of N-acetyl impurities and completely removes the by-product dicyclohexylurea (DCU), eliminating the need for additional purification steps.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents